Announcement

Collapse
No announcement yet.

Euro Surveill. Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Euro Surveill. Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013

    [Source: Eurosurveillance, full page: (LINK). Abstract, edited.]


    Eurosurveillance, Volume 18, Issue 49, 05 December 2013

    Rapid communications

    Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013

    M Murti <SUP>1</SUP>, M Krajden<SUP>2</SUP>, M Petric<SUP>2</SUP>, J Hiebert<SUP>3</SUP>, F Hemming<SUP>1</SUP>, B Hefford<SUP>4</SUP>, M Bigham<SUP>1</SUP>, P Van Buynder<SUP>1</SUP>
    <SUP></SUP>
    <SUP>1</SUP>Fraser Health Authority, Surrey, British Columbia, Canada ? 2 Public Health Microbiology and Reference Laboratory British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada - 3 National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada - 4 1-1400 George St., White Rock, British Columbia, Canada
    ________

    Citation style for this article: Murti M, Krajden M, Petric M, Hiebert J, Hemming F, Hefford B, Bigham M, Van Buynder P. Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013. Euro Surveill. 2013;18(49):pii=20649. Available online: http://www.eurosurveillance.org/View...rticleId=20649
    Date of submission: 15 November 2013

    ________

    We describe a case of vaccine-associated measles in a two-year-old patient from British Columbia, Canada, in October 2013, who received her first dose of measles-containing vaccine 37 days prior to onset of prodromal symptoms. Identification of this delayed vaccine-associated case occurred in the context of an outbreak investigation of a measles cluster.


    -
    ---------
Working...
X